Latest news
October 31, 2007
Ipsen and Debiopharm extend their Agreement for the Exclusive Commercialization of Decapeptyl®
October 31, 2007
Debiopharm and Nanocarrier sign License and Supply Agreement for DACH-Platin Polymeric Micelle in Oncology
May 24, 2007
Salvacyl®/ Maopar® 3-month obtains european mutual recognition to treat sexual deviations
April 19, 2007
Clinical update – Debio 025 cyclophilin inhibitor for the treatment of HCV – A unique viral kinetics